Filter News
Area of Research
- (-) Computational Biology (1)
- (-) Materials for Computing (1)
- (-) National Security (1)
- Advanced Manufacturing (1)
- Biology and Environment (6)
- Clean Energy (12)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (6)
- Fusion Energy (1)
- Isotopes (11)
- Materials (1)
- Neutron Science (3)
- Nuclear Science and Technology (1)
- Sensors and Controls (1)
- Supercomputing (7)
News Type
News Topics
- (-) Biomedical (1)
- (-) Isotopes (1)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (2)
- Biology (1)
- Chemical Sciences (4)
- Composites (1)
- Computer Science (6)
- Coronavirus (3)
- Cybersecurity (3)
- Energy Storage (1)
- Environment (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (9)
- Microscopy (3)
- Nanotechnology (4)
- National Security (5)
- Neutron Science (5)
- Polymers (4)
- Quantum Computing (1)
- Quantum Science (3)
- Sustainable Energy (2)
- Transportation (2)
Media Contacts
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy